MENU

MEOBF Stock MEOBF is expected to report earnings to fall -67% to -2 cents per share on May 29

A.I.dvisor
at Tickeron.com
Loading...
MEOBF - Mesoblast Ltd.
Mesoblast Ltd. Earnings Graph
Q1'24
Est.
$-0.02
Q3'24
Est.
$-0.01
Q4'23
Est.
$-0.02
Q3'23
Est.
$-0.02
Q2'23
Beat
by $0.01
The last earnings report on September 30 showed earnings per share of -1 cents, meeting the estimate of -1 cents. P/B Ratio (4.301) is normal, around the industry mean (12.593). P/E Ratio (0.000) is within average values for comparable stocks, (85.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). MEOBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (151.515) is also within normal values, averaging (252.567). With 1.95K shares outstanding, the current market capitalization sits at 2.33B.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com